Explore

Cell Signaling 2017

Annual summit on Cell Signaling and Cancer Therapy 2017

chicago, United States
27 - 28 September 2017
The conference ended on 28 September 2017

Important Dates

Abstract Submission Deadline
27th July 2017
Early Bird Deadline
27th July 2017
Abstract Acceptance Notification
2nd August 2017
Final Abstract / Full Paper Deadline
15th September 2017

About Cell Signaling 2017

Annual Summit on Cell Signaling and Cancer Therapy is bustling to be held at Chicago, USA during September 27-28, 2017 hosted by Conferences Series. Through the theme "To Frame An Admiring Portal For Pioneering Cancer Therapy and Cell Signaling Findings", conference will explore the advances in Medical Approaches, Oncology, Translational Oncology, Computational Technologies, etc. This conference brings a novel and International mixture of giant and medium cancer therapy and cell signaling analysis, leading universities and cancer analysis establishments creating the conference an excellent platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world.

Topics

Cancer research, Cell biology, Protein folding, Radiology, Stem cell, Stem cell research, Cell therapy, Immunotherapy

Call for Papers

Call for papers:

Conference highlights

  ·         Cell Signaling ·         Modes of Signaling & Signaling Pathways ·         Protein Signaling & Neuronal Signaling ·         Signaling Defect and Diseases ·         Cell Adhesion and Cell Communication ·         Advanced Approach in Cell Signaling ·         Cancer Therapy ·         Radiation Therapy ·         Chemotherapy ·         Immunotherapy & Targeted Therapy ·         Cancer Stem Cell Therapy ·         Common & Novel Therapies in Cancer Treatment ·         System biology

Abstract submission opens: December 19, 2016,    Registration opens: January 2, 2017,Early bird registration: July 27, 2017 On spot registration: September 27, 2017

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.